Keyword Search: Gene Ontology, PubMed or Web (Google)

PDB Keywords for 3ZJD

(Keywords from the PDB file are used here. They may or may not correspond to GO term names).

• Hydrolase|Ubiquitin|Deubiquitinating Enzyme|Reversible Oxidation|Sulphenic Acid|Cys Protease [GO] [PubMed] [Google]

GO Keywords for 3ZJD

(Here all GO term names are given that map directly to this particular structure).

• B-1 B cell homeostasis [GO] [PubMed] [Google]
• protease binding [GO] [PubMed] [Google]
• response to molecule of bacterial origin [GO] [PubMed] [Google]
• regulation of germinal center formation [GO] [PubMed] [Google]
• negative regulation of chronic inflammatory response [GO] [PubMed] [Google]
• DNA binding [GO] [PubMed] [Google]
• catalytic activity [GO] [PubMed] [Google]
• ubiquitin-protein transferase activity [GO] [PubMed] [Google]
• thiol-dependent ubiquitin-specific protease activity [GO] [PubMed] [Google]
• protein binding [GO] [PubMed] [Google]
• nucleus [GO] [PubMed] [Google]
• cytoplasm [GO] [PubMed] [Google]
• lysosome [GO] [PubMed] [Google]
• cytosol [GO] [PubMed] [Google]
• proteolysis [GO] [PubMed] [Google]
• apoptotic process [GO] [PubMed] [Google]
• inflammatory response [GO] [PubMed] [Google]
• metabolic process [GO] [PubMed] [Google]
• peptidase activity [GO] [PubMed] [Google]
• cysteine-type peptidase activity [GO] [PubMed] [Google]
• zinc ion binding [GO] [PubMed] [Google]
• regulation of tumor necrosis factor-mediated signaling pathway [GO] [PubMed] [Google]
• protein ubiquitination [GO] [PubMed] [Google]
• protein deubiquitination [GO] [PubMed] [Google]
• hydrolase activity [GO] [PubMed] [Google]
• ligase activity [GO] [PubMed] [Google]
• kinase binding [GO] [PubMed] [Google]
• negative regulation of protein ubiquitination [GO] [PubMed] [Google]
• negative regulation of NF-kappaB transcription factor activity [GO] [PubMed] [Google]
• negative regulation of type I interferon production [GO] [PubMed] [Google]
• response to muramyl dipeptide [GO] [PubMed] [Google]
• negative regulation of interleukin-1 beta production [GO] [PubMed] [Google]
• negative regulation of interleukin-2 production [GO] [PubMed] [Google]
• negative regulation of interleukin-6 production [GO] [PubMed] [Google]
• negative regulation of tumor necrosis factor production [GO] [PubMed] [Google]
• negative regulation of toll-like receptor 2 signaling pathway [GO] [PubMed] [Google]
• negative regulation of toll-like receptor 3 signaling pathway [GO] [PubMed] [Google]
• negative regulation of toll-like receptor 4 signaling pathway [GO] [PubMed] [Google]
• negative regulation of toll-like receptor 5 signaling pathway [GO] [PubMed] [Google]
• protein K11-linked deubiquitination [GO] [PubMed] [Google]
• thiol-dependent ubiquitinyl hydrolase activity [GO] [PubMed] [Google]
• negative regulation of I-kappaB kinase/NF-kappaB signaling [GO] [PubMed] [Google]
• ubiquitin binding [GO] [PubMed] [Google]
• protein self-association [GO] [PubMed] [Google]
• positive regulation of protein catabolic process [GO] [PubMed] [Google]
• negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO] [PubMed] [Google]
• negative regulation of bone resorption [GO] [PubMed] [Google]
• negative regulation of innate immune response [GO] [PubMed] [Google]
• metal ion binding [GO] [PubMed] [Google]
• negative regulation of smooth muscle cell proliferation [GO] [PubMed] [Google]
• regulation of defense response to virus by host [GO] [PubMed] [Google]
• regulation of inflammatory response [GO] [PubMed] [Google]
• negative regulation of inflammatory response [GO] [PubMed] [Google]
• negative regulation of B cell activation [GO] [PubMed] [Google]
• protein complex oligomerization [GO] [PubMed] [Google]
• negative regulation of cell death [GO] [PubMed] [Google]
• regulation of vascular wound healing [GO] [PubMed] [Google]
• extracellular exosome [GO] [PubMed] [Google]
• cellular response to hydrogen peroxide [GO] [PubMed] [Google]
• nucleotide-binding oligomerization domain containing signaling pathway [GO] [PubMed] [Google]
• negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO] [PubMed] [Google]
• negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO] [PubMed] [Google]
• K63-linked polyubiquitin modification-dependent protein binding [GO] [PubMed] [Google]
• protein K63-linked deubiquitination [GO] [PubMed] [Google]
• protein K48-linked ubiquitination [GO] [PubMed] [Google]
• protein K48-linked deubiquitination [GO] [PubMed] [Google]
• cellular response to lipopolysaccharide [GO] [PubMed] [Google]
• protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO] [PubMed] [Google]
• tolerance induction to lipopolysaccharide [GO] [PubMed] [Google]
• establishment of protein localization to vacuole [GO] [PubMed] [Google]
• negative regulation of osteoclast proliferation [GO] [PubMed] [Google]
• negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO] [PubMed] [Google]
• positive regulation of cellular protein catabolic process [GO] [PubMed] [Google]
• positive regulation of hepatocyte proliferation [GO] [PubMed] [Google]
• negative regulation of CD40 signaling pathway [GO] [PubMed] [Google]
• negative regulation of endothelial cell apoptotic process [GO] [PubMed] [Google]